MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, FBIOP has $356,874K in assets. $154,500K in debts. $255,841K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
285.78%
Quick Ratio
276.80%
Cash Ratio
247.45%
Debt to Asset Ratio
43.29%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Equity investments, at fair valu...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
255,841 79,381 86,218 74,386
Assets held for sale
-0 0 0
Accounts receivable, net
24,992 29,783 17,983 15,644
Inventory
9,292 9,624 11,818 12,852
Other receivables
516 158 142 558
Prepaid expenses and other current assets
4,839 4,895 2,342 6,956
Total current assets
295,480 123,841 118,503 110,396
Property, plant and equipment, net
2,426 2,519 2,611 2,704
Operating lease right-of-use asset, net
11,822 12,302 12,321 12,817
Restricted cash
1,220 1,220 1,220 1,220
Equity investments, at fair value
18,707 17,660 --
Intangible assets, net
26,479 27,605 28,670 29,734
Other assets
740 401 18,082 3,024
Total assets
356,874 185,548 181,407 159,895
Accounts payable and accrued expenses
92,986 47,125 45,171 48,576
Income taxes payable
5,418 356 1,005 984
Common stock warrant liabilities
0 1 2 0
Operating lease liabilities, short-term
2,221 2,127 2,129 2,140
Partner company notes payable, short-term
2,500 -5,625 3,750
Partner company installment payments - licenses, short-term
-0 0 0
Other current liabilities
268 135 135 2,071
Total current liabilities
103,393 49,744 54,067 57,521
Notes payable, long-term
36,878 52,417 47,774 50,026
Operating lease liabilities, long-term
12,028 12,672 12,765 13,303
Partner company redeemable perpetual preferred liability
0 7,085 --
Other long-term liabilities
2,201 1,447 1,616 1,662
Total liabilities
154,500 123,365 116,222 122,512
Cumulative redeemable perpetual preferred stock, 0.001 par value, 15,000,000 authorized, 5,000,000 designated series a shares, 3,427,138 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively, liquidation value of 25.00 per share
3 3 3 3
Common stock, 0.001 par value, 200,000,000 shares authorized, 33,186,671 and 31,364,094 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
33 31 31 30
Additional paid-in-capital
785,851 783,891 785,943 779,856
Accumulated deficit
-623,679 -734,052 -730,115 -735,965
Total stockholders' equity attributed to the company
162,208 49,873 55,862 43,924
Non-controlling interests
40,166 12,310 9,323 -6,541
Total stockholders' equity
202,374 62,183 65,185 37,383
Total liabilities and stockholders' equity
356,874 185,548 181,407 159,895
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$255,841K Accounts receivable, net$24,992K Inventory$9,292K Prepaid expenses andother current assets$4,839K Other receivables$516K Total current assets$295,480K Intangible assets, net$26,479K Equity investments, atfair value$18,707K Operating leaseright-of-use asset, net$11,822K Property, plant andequipment, net$2,426K Restricted cash$1,220K Other assets$740K Total assets$356,874K Total liabilities andstockholders' equity$356,874K Total stockholders'equity$202,374K Total liabilities$154,500K Total stockholders'equity attributed to...$162,208K Non-controlling interests$40,166K Total currentliabilities$103,393K Notes payable,long-term$36,878K Operating leaseliabilities, long-term$12,028K Other long-termliabilities$2,201K Accumulated deficit-$623,679K Additionalpaid-in-capital$785,851K Accounts payable andaccrued expenses$92,986K Income taxes payable$5,418K Partner company notespayable, short-term$2,500K Operating leaseliabilities, short-term$2,221K Other currentliabilities$268K Common stock, 0.001 parvalue, 200,000,000...$33K Cumulative redeemableperpetual preferred...$3K

Fortress Biotech, Inc. (FBIOP)

Fortress Biotech, Inc. (FBIOP)